Magstim Awarded FDA (510K) Clearance for Advanced Transcranial Magnetic Stimulation (TMS) Platform Horizon 3.0
New Class of Navigated TMS Delivers Customized, Repeatable Treatments Improving Patient Care and Clinical Efficiencies Magstim, the global leader in neuroscience research and treatment for mental
United States Telegraph Hill San Francisco Kostenloser Wertpapierhandel Mark Sejvar Magstim Stimguide
Source: finanznachrichten.de